Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
80.84 USD | +1.63% | +4.39% | +4.56% |
May. 06 | Argus Adjusts Price Target on Bio-Techne to $95 From $90, Keeps Buy Rating | MT |
May. 02 | UBS Adjusts Price Target on Bio-Techne to $90 From $80, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.56% | 12.55B | |
+19.77% | 47.02B | |
+49.28% | 41.86B | |
+0.31% | 41.76B | |
-4.27% | 28.8B | |
+11.80% | 26.05B | |
-22.20% | 19.15B | |
+28.71% | 12.34B | |
-4.15% | 11.82B | |
+21.54% | 11.8B |
- Stock Market
- Equities
- TECH Stock
- News Bio-Techne Corporation
- Bio-Techne Positioned for Growth Amid Biotech Funding Recovery, UBS Says